The efficacy of anti-PD-1/PD-L1 therapy and its comparison with EGFR-TKIs for advanced non-small-cell lung cancer.
about
Immunotherapy "Shock" with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma.Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer.Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review).Role of Immunotherapy for Oncogene-Driven Non-Small Cell Lung CancerBiomarkers for predicting efficacy of PD-1/PD-L1 inhibitorsPembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expressionAnti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized Medicine and Combination Strategies
P2860
Q47105617-B8FBB10B-1F10-45A9-87A7-72ED8EA7AA48Q52641579-B4E7A764-5F67-49E8-8B91-2A9486C4C977Q52683991-62C3DCF9-DD71-4F63-890D-ECDABBF7EE24Q57174372-8DF64328-CAF4-4A03-AE72-74EF49ECEC40Q58713932-71BCEA40-C491-41F0-AF9A-5AAC76CA370DQ58759053-70DAB6EA-1C19-4D75-BAC1-F0B333ED3175Q58795231-5120729E-B8D9-4283-BA6D-7AE4641FE52E
P2860
The efficacy of anti-PD-1/PD-L1 therapy and its comparison with EGFR-TKIs for advanced non-small-cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The efficacy of anti-PD-1/PD-L ...... ed non-small-cell lung cancer.
@en
type
label
The efficacy of anti-PD-1/PD-L ...... ed non-small-cell lung cancer.
@en
prefLabel
The efficacy of anti-PD-1/PD-L ...... ed non-small-cell lung cancer.
@en
P2093
P2860
P356
P1433
P1476
The efficacy of anti-PD-1/PD-L ...... ed non-small-cell lung cancer.
@en
P2093
Yanhua Sun
Yanxia Zhang
Zhixin Sheng
P2860
P304
57826-57835
P356
10.18632/ONCOTARGET.18406
P407
P577
2017-06-08T00:00:00Z